ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Angel Oak Ultrashort Income ETF

Angel Oak Ultrashort Income ETF (UYLD)

51.0019
0.0119
( 0.02% )
Updated: 11:54:20

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
51.0019
Bid
-
Ask
-
Volume
2,264
50.98 Day's Range 51.0019
50.31 52 Week Range 53.40
Previous Close
50.99
Open
50.98
Last Trade
1800
@
51.0019
Last Trade Time
11:54:20
Average Volume (3m)
38,540
Financial Volume
$ 115,462
VWAP
50.9991

UYLD Latest News

Angel Oak Capital Advisors’ ETF Platform Surpasses $1 Billion in AUM

Less than two years since inception, the firm’s suite of ETFs continues to grow, finding success in solving for potential gaps in advisor and institutional portfolios Angel Oak Capital Advisors...

Angel Oak Capital Advisors Completes Conversion of Two Mutual Funds to ETFs

Angel Oak’s Conversions Bring New Opportunities to Advisors, Investors Seeking Actively Managed ETFs in Structured Credit and High Yield Angel Oak Capital Advisors, LLC, an investment management...

Angel Oak Capital Advisors Continues Success With ETF Platform as Angel Oak Income ETF Crosses $100 Million in Assets Under Management

Angel Oak Capital Advisors LLC (Angel Oak), an investment management firm that specializes in value-driven structured credit, announced that the firm continues to find traction in its...

Angel Oak Capital Advisors’ UltraShort Income ETF Surpasses $100M in Assets in One Year, Sets Stage for ETF Platform Growth in 2024

The structured credit-focused investment shop finds success in delivering distinct income solutions under the exchange-traded fund wrapper, sub-advisory services Angel Oak Capital Advisors LLC...

Angel Oak Capital Advisors’ UltraShort Income ETF Surpasses $100M in Assets in One Year, Sets Stage for ETF Platform Growth in 2024

The structured credit-focused investment shop finds success in delivering distinct income solutions under the exchange-traded fund wrapper, sub-advisory services Angel Oak Capital Advisors LLC...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.05190.10186457311150.9551.0250.89814756150.98748556SP
40.02190.04295802275450.9851.1150.824417551.01361102SP
120.06190.12151550844150.9451.1350.753854050.96887471SP
260.32190.63516179952650.6853.450.557295450.88272206SP
520.60191.1942460317550.453.450.314223850.83390791SP
1560.96191.9222621902550.0454.7850.022959350.75141641SP
2600.96191.9222621902550.0454.7850.022959350.75141641SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KZIAKazia Therapeutics Ltd
$ 0.7958
(314.48%)
293.05M
VRPXVirpax Pharmaceuticals Inc
$ 2.3498
(102.57%)
104.56M
QUREuniQure NV
$ 10.2472
(53.63%)
30.95M
LGVNLongeveron Inc
$ 4.308
(50.10%)
89.47M
VVPRVivoPower International PLC
$ 3.769
(47.80%)
33.89M
ZAPPZapp Electric Vehicles Group Ltd
$ 10.48
(-41.62%)
5.53M
SISIShineco Inc
$ 2.66
(-41.02%)
942.3k
ICUSeaStar Medical Holding Corporation
$ 8.61
(-33.77%)
780.61k
AFCGAFC Gamma Inc
$ 8.4799
(-27.02%)
201.01k
LZLegalZoom com Inc
$ 5.805
(-26.05%)
7.42M
KZIAKazia Therapeutics Ltd
$ 0.7958
(314.48%)
293.05M
MAXNMaxeon Solar Technologies Ltd
$ 0.2125
(-14.31%)
146.22M
NVDANVIDIA Corporation
$ 134.21
(2.15%)
120.18M
VRPXVirpax Pharmaceuticals Inc
$ 2.3498
(102.57%)
104.56M
LGVNLongeveron Inc
$ 4.308
(50.10%)
89.47M

Discussion

View Full Feed
Dj56 Dj56 4 minutes ago
The federal government can print , create the money...albeit since 1914 through the FED, and give the NIH monies it figures RSPI needs to complete human trials.

NIH was established to promote the finding of a safe, effective nonopiode.

NIH eventually, if other sources b
RSPI
LTListener LTListener 4 minutes ago
Can't imagine what those meetings with BP or major funding would look like...

How could any deal be trusted? Oh please go find us grant money, we wont EMBARRASS you...

Retail supporters, who cares STOMP.
RSPI
 just Scottie just Scottie 4 minutes ago
Can’t argue with that
SFLM
RealDutch RealDutch 4 minutes ago
I think this is him. He posted this on Nov 3, 2021. One day after the article was published,

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166618675
ITUP
Tahoe2468 Tahoe2468 5 minutes ago
NAAS NAAS NAAS
NAAS
TIMGZ TIMGZ 5 minutes ago
WAS $54 PRE MARKET, CHAA MERGER NEW TICKER, MIGHT RUN AGAIN
Awl416 Awl416 5 minutes ago
Almost at a double from last week
RTC
CaptainObvious CaptainObvious 5 minutes ago
You, of course, are ignoring the fact explained many times here, that his circumstances changed and did not have to sell at all.
NWBO
Awl416 Awl416 5 minutes ago
Let me know when
DRMA
NASDAQ2020 NASDAQ2020 6 minutes ago
Adderall $0.35
Generic OxyContin $0.40
Generic Vyvance $0.75
Generic Concerta $0.35
ELTP
Lazarus Elite Lazarus Elite 6 minutes ago
Net Income: $20 million
Net Income Estimated 2025: $30 million minimum
$7 Billion (Vyvance, Oxy, 3 drug buyback) in expected approvals @ 5% Market penetration: $350 million
Estimated additional net income from $350 million in revenue: $140 million
$170 million purchased
ELTP
drugmanrx drugmanrx 6 minutes ago
Very simple.
I'm doing some research here and everything sounds great except the fact that the company keeps postponing dates.

The micro cap company (SAPX) is at the mercy and the whim of the large cap company, (STARZ) they are working with in terms of what can be said and whe
SAPX
vlispxpert vlispxpert 6 minutes ago
KALA, I yelled buy buy buy:

https://schrts.co/BNIiArMY
fredscott36 fredscott36 6 minutes ago
no comment on Neal's position......relative to sonterra/LIBOR......he made public statements when we were venue shopping, and he was adamantly opposed......but Neal makes a living, sucking off of banks.............and hating on the FASCIST regulators.......................

on sonterra
Waalrus Waalrus 6 minutes ago
Thats very re assuring. Thank you. Maybe, that is the ‘wrinkle’ that you referred to earlier during uplisting?
AHRO
TIMGZ TIMGZ 6 minutes ago
NEW MERGER/BUSINESS COMBINATION, USED TO BE "CHAA"
Vettelover98 Vettelover98 7 minutes ago
Cost basis is zero, I’m just enjoying the ride. Go $VPLM!!
VPLM
Natural Trader Natural Trader 7 minutes ago
JAGX 4.30 catalyst next few days : On or before July 23, 2024: Results of pivotal phase 3 OnTarget trial of crofelemer for prophylaxis of cancer therapy-related diarrhea (CTD) - Chemotherapy-induced overactive bowel (CIOB)
JAGX
Lime Time Lime Time 7 minutes ago
Smart Peeps scooping up cheapies
GVSI
I-Glow I-Glow 7 minutes ago
You couldn't be more wrong - that would be securities fraud. "Right or wrong? The mms objective is to fleece as many retail shares as possible before it runs?"

That is a hard No.

On the OTCM a MM is to provide liquidity to an illiquid market.

The MMs aren
SPZI
ecoblot ecoblot 8 minutes ago
OPXS(7.79). Hard to believe i was at 7 2 days ago. Thanks HWeb for the alert
Awl416 Awl416 8 minutes ago
Looks ready to halt
NAAS
Monroe1 Monroe1 8 minutes ago
We are grateful having boots on the ground. Keep on keeping on!
NBRI

Your Recent History

Delayed Upgrade Clock